Osteofibrous dysplasia: a narrative review
Rui Liu1, Linjian Tong1, Haiyang Wu2
1Clinical College of Neurology, Neurosurgery and Neurorehabilitation, Tianjin Medical University, Tianjin, 300070, China.
Journal of Orthopaedic Surgery and Research
|March 28, 2024
Summary
Osteofibrous dysplasia (OFD) is a rare bone tumor, often misdiagnosed as adamantinoma. This review clarifies OFD
Area of Science:
- Orthopedic Oncology
- Pathology
- Radiology
Background:
- Osteofibrous dysplasia (OFD) is a rare, benign, self-limited bone disorder.
- It accounts for approximately 0.2% of primary bone tumors, typically found in the tibial mid-shaft.
- OFD can affect various skeletal sites and present with diverse symptoms, including asymptomatic findings, mass, pain, swelling, deformity, or pathological fracture.
Purpose of the Study:
- To provide a comprehensive overview of Osteofibrous dysplasia (OFD).
- To enhance understanding of its epidemiology, clinical signs, pathogenesis, radiological and pathological features.
- To guide accurate diagnosis and appropriate treatment of OFD.
Main Methods:
- Literature review and synthesis of existing studies on Osteofibrous dysplasia.
- Analysis of clinical manifestations, diagnostic imaging, and histopathological findings.
- Discussion of differential diagnoses, particularly adamantinoma.
Main Results:
- Osteofibrous dysplasia shares similarities with adamantinoma, leading to potential misdiagnosis.
- Accurate diagnosis relies on comprehensive evaluation of clinical, radiological, and pathological data.
- Small biopsy samples can contribute to diagnostic errors.
Conclusions:
- Improved understanding of OFD's characteristics is crucial for accurate diagnosis.
- Distinguishing OFD from adamantinoma requires careful assessment.
- This review aims to improve clinical management of Osteofibrous dysplasia.
More Related Videos
Related Concept Videos
Osteoclasts in Bone Remodeling
2.9K
Osteoclasts are cells responsible for bone resorption and remodeling. They originate from hematopoietic progenitor cells present in the bone marrow. Numerous progenitor cells fuse to form multinucleated cells, each with 10-20 nuclei. A single osteoclast has a diameter of 150 to 200 µM. These cells have ruffled borders that break down the underlying bone tissue and release minerals such as calcium into the blood in bone resorption. Osteoclasts cling to bones with their ruffled edges during...
2.9K
Bone Remodeling
38.3K
Bone remodeling is a continuous and balanced process of bone resorption by osteoclasts and bone formation by osteoblasts. In adults, it helps maintain bone mass and calcium homeostasis. While mechanical stress can stimulate turnover as part of the normal maintenance and reparative process, several hormones also regulate bone remodeling.
38.3K
Fractures: Bone Repair
3.2K
Treatment for a fracture is based on the type of break, the bone affected, and the patient's age.
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
Minor fractures with no bone displacement are treated by immobilizing the fractured bone using a cast or splint. However, in the case of fractures with displaced bones, the broken bones are repositioned before immobilization to ensure successful healing without deformation and loss of function. The realignment of fractured bone ends is performed through a process called reduction. If the...
3.2K


